Inferra AI / Company / XRAY
Dentsply Sirona Inc..
XRAY · Health Care
Last earnings Aug 7, 2026
Key results
GAAP gross marginquarter
52.4%
GAAP gross margin of 52.4%, GAAP net loss per share of ($0.22)
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
AI analysis
Q2 2025 · reported Aug 7, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance · company-stated
No guidance located in the held release
“3 million shares of common stock during the quarter Reiterates 2026 outlook for net sales and adjusted EPS Charlotte, N.”
Margin
Capital allocation
htm EX-99.1 Document Dentsply Sirona Reports Second Quarter 2025 Results Net sales of $936 million decreased (4.9%), decreased (6.7%) in constant currency including a (3.2%) Byte sales impact GAAP gross margin of 52.4%, GAAP net loss per share of ($0.22) Adjusted gross margin of 55.9%, adjusted EBITDA margin of 21.1%, adjusted EPS of $0.52 Executed $550 million debt offering Reaffirmed FY25 outlook Leadership transition with Dan Scavilla appointed CEO effective August 1, 2025 and Matt Garth appointed CFO effective May 30, 2025 Charlotte, N.
Event summary
Adjusted earnings per diluted share were $0.52, compared to $0.49 in the second quarter of 2024
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
htm EX-99.1 Document Dentsply Sirona Reports Second Quarter 2025 Results Net sales of $936 million decreased (4.9%), decreased (6.7%) in constant currency including a (3.2%) Byte sales impact GAAP gross margin of 52.4%, GAAP net loss per share of ($0.22) Adjusted gross margin of 55.9%, adjusted EBITDA margin of 21.1%, adjusted EPS of $0.52 Executed $550 million debt offering Reaffirmed FY25 outlook Leadership transition with Dan Scavilla appointed CEO effective August 1, 2025 and Matt Garth appointed CFO effective May 30, 2025 Charlotte, N.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
In the second quarter of 2025, the Company paid $32 million in dividends resulting in a total of $64 million returned to stockholders in the first six months of 2025.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
On June, 12, 2025, the Company issued $550 million aggregate principal amount of 8.375% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055 through a public offering, the proceeds of which were used to repay outstanding amounts under the Company's bridge loan facility and for general corporate purposes.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
On July 1, 2025, the Company entered into a series of interest rate swap contracts to manage interest rate risk on long-term debt instruments.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Quarterly Cash Dividend On July 31, 2025, the Company's Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
The dividend is payable on October 10, 2025, to holders of record as of September 26, 2025.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Strategy & priorities
While top-line results were down in the quarter, we were pleased to continue to deliver margin expansion, said Matt Garth, Chief Financial Officer.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
We increased our financial flexibility, drove adjusted EPS growth and are actively focused on enhancing cash flow generation to support the long-term profitable growth of the Company.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
As we move forward, we plan to advance our initiatives, remain disciplined in our capital allocation, and deliver sustainable value for our shareholders.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Although the Company is regularly engaged in activities to find and act on opportunities for strategic growth and enhancement of product offerings, the costs associated with these activities may vary significantly between periods based on the timing, size and complexity of acquisitions and as such may not be indicative of past and future performance of the Company.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
These adjustments include costs related to the implementation of restructuring initiatives, including but not limited to, severance costs, facility closure costs, and lease and contract termination costs, as well as related professional service costs associated with these restructuring initiatives and global transformation activity.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Risks & headwinds
These impairments were driven by the impacts from tariffs and lower volumes in implants and prosthetics and equipment, due partly to competitive pressures.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
This outlook reflects the current state of tariffs and trade policy.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control, including those described in Part I, Item 1A, Risk Factors of the Company's most recent Annual Report on Form 10-K, Part II, Item 1A, Risk Factors of the Company's Quarterly Reports on Form 10-Q for any subsequent fiscal quarters, and any updating information or other factors which may be described in the Company's other filings with the Securities and Exchange Commission (the SEC ).
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
As such, you should not consider the risks identified in the Company's SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.
SEC original ↗Dentsply Sirona Inc.. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
These statements represent current expectations and beliefs, and are subject to numerous assumptions, risks, uncertainties, and other factors that could cause actual results to differ materially from those described in such statements.
SEC original ↗Dentsply Sirona Inc.. — 10-Q Quarterly report10-QAug 6, 2026
As such, you should not consider the risks identified in the Company s SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.
SEC original ↗Dentsply Sirona Inc.. — 10-Q Quarterly report10-QAug 6, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
34 documents- Q3 2026
- 8-KXRAY
Oct 9, 2026
- Q2 2026
- 8-K/AXRAY
Aug 7, 2026
- 8-KXRAY
Aug 6, 2026
- 10-QXRAY
- Q1 2026
- 8-KXRAY
Jun 11, 2026
- 8-KXRAY
Jun 4, 2026
- 8-KXRAY
May 5, 2026
- EX-99XRAY
May 5, 2026
- 10-QXRAY
- Q4 2025
- 8-KXRAY
Feb 26, 2026
- 10-KXRAY
Feb 26, 2026
- 8-KXRAY
Feb 24, 2026
- EX-99XRAY
Feb 24, 2026
- 8-KXRAY
Jan 14, 2026
- EX-99XRAY
Jan 14, 2026
- 8-KXRAY
Jan 13, 2026
- EX-99XRAY
Jan 13, 2026
- Q3 2025
- 8-KXRAY
Dec 31, 2025
- 8-KXRAY
Nov 25, 2025
- 8-K/AXRAY
Nov 7, 2025
- 8-KXRAY
Nov 6, 2025
- 8-KXRAY
Nov 6, 2025
- 10-QXRAY
- 8-KXRAY
Oct 14, 2025
- 8-KXRAY
Oct 3, 2025
- Q2 2025
- 8-KXRAY
Sep 19, 2025
- 8-KXRAY
Sep 8, 2025
- 8-KXRAY
Aug 7, 2025
- 10-QXRAY
- 8-KXRAY
Jul 21, 2025
- Q1 2025
- 8-KXRAY
Jun 12, 2025
- 8-KXRAY
Jun 6, 2025
- 8-KXRAY
Jun 4, 2025
- 8-KXRAY
May 29, 2025
Earnings releases
8 documentsPresentations
0 documentsNo presentations for Dentsply Sirona Inc.. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Dentsply Sirona Inc.. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.